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The Chlamydia trachomatis serine protease HtrA (CtHtrA) has recently been demonstrated
to be essential during the replicative phase of the chlamydial developmental cycle.
A chemical inhibition strategy (serine protease inhibitor JO146) was used to demonstrate
this essential role and it was found that the chlamydial inclusions diminish in size and
are lost from the cell after CtHtrA inhibition without formation of viable elementary
bodies. The inhibitor (JO146) was used in this study to investigate the role of CtHtrA
for penicillin persistence and heat stress conditions for Chlamydia trachomatis. JO146
addition during penicillin persistence resulted in only minor reductions (∼1 log) in the
final viable infectious yield after persistent Chlamydia were reverted from persistence.
However, JO146 treatment during the reversion and recovery from penicillin persistence
was completely lethal for Chlamydia trachomatis. JO146 was completely lethal when
added either during heat stress conditions, or during the recovery from heat stress
conditions. These data together indicate that CtHtrA has essential roles during some
stress environments (heat shock), recovery from stress environments (heat shock and
penicillin persistence), as well as the previously characterized essential role during the
replicative phase of the chlamydial developmental cycle. Thus, CtHtrA is an essential
protease with both replicative phase and stress condition functions for Chlamydia
trachomatis.
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INTRODUCTION
Chlamydia trachomatis is a unique obligate intracellular bacterial
pathogen. The organism is typified by a bi-phasic developmen-
tal cycle. This cycle consists of an infectious extracellular form,
termed the elementary body (EB), and an intracellular replicative
form termed the reticulate body (RB), which divides by binary fis-
sion prior to converting back to the infectious progeny (reviewed,
Adbelrahman and Belland, 2005). The intracellular form is found
inside a unique vacuole inside the host cell that is called the inclu-
sion vacuole. In addition to these two forms, the organism has
a “latent” like phase of intracellular growth. This is termed per-
sistence that is defined as viable but non-cultivatable Chlamydia.
Persistent Chlamydia (also called aberrant bodies), are morpho-
logically distinct from the active replicating form with only a few
cells visible per inclusion which are much larger size) (Moulder,
1993; Byrne et al., 2001; Hogan et al., 2004; Wyrick, 2010). This
ability to become persistent is thought to provide the organism
with a survival mechanism to avoid any conditions where they
would be unable to survive. Hence, persistence is induced by
immune pressure, amino acid deprivation, penicillin, iron lim-
itation, or the presence of other intracellular pathogens (Beatty
et al., 1993, 1994a,b; Coles et al., 1993; Byrne et al., 2001; Wyrick
and Knight, 2004; CDC, 2005–2009/2010; Deka et al., 2006).
Whilst there are numerous means of inducing persistence and the
chlamydial cellular morphology appears similar for each of these,
it is clear that there are distinct transcriptional and protein pro-
files associated with the different forms of persistence (reviewed,
Wyrick, 2010).
Amino acid deprivation has been shown to induce persis-
tence, which was able to be restored by cysteine and isoleucine
(Coles et al., 1993; Harper et al., 2000). The best characterized
mechanism of persistence is that induced by IFN- γ (interferon-
gamma). IFN- γ (secreted by immune cells) induces a large range
of responses in the epithelial cell (Beatty et al., 1993, 1994a). One
of the proteins that is highly induced in human epithelial cells
in response to IFN- γ is IDO1 (indoleamine 2,3-dioxygenase)
(Beatty et al., 1993, 1994a; Ibana et al., 2011). This enzyme catab-
olizes the host cell tryptophan resulting in reduced tryptophan
supply for the auxotrophic pathogen. C. trachomatis persistence
induced by IFN- γ is able to be reverted by the removal of IFN-
γ and addition of tryptophan. IFN- γ aberrant bodies are typ-
ified by a loss of expression of genes required for cytokinesis
with continuing chromosomal replication (Byrne et al., 2001;
Belland et al., 2003). Another commonly used laboratory model
of persistence is that which occurs in response to cell wall tar-
geting antibiotics. Models of this form of persistence typically
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FIGURE 1 | Flow chart diagrams of methodologies used in this
manuscript with cartoon representations of the expected growth phases
of the Chlamydia. (A) Key to the components of a Chlamydia-infected host
cell. Small, open circles: elementary bodies (EB); large black circles: reticulate
bodies (RB); large gray circles: aberrant bodies (AB); green circle: host cell;
yellow circle: chlamydial inclusion vacuole. (B) The Chlamydia trachomatis
(serovar D) development cycle is represented by the cartoon. The relative
(Continued)
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FIGURE 1 | Continued
time-points are shown below the cells and each stage of the cycle is shown
in gray arrows above the cells. (C) Experimental conditions used to assess
the impact of JO146 addition during penicillin persistence. (D) Experimental
plan to determine the impact of JO146 on C. trachomatis reversion from
persistence. (E) Experimental plan to use the JO146 inhibitor to determine
the role of CtHtrA for viability of C. trachomatis during heat stress conditions.
The pink boxes represent the experimental actions taken, with arrows
extending to the specific time-point for each action. The viability and/or
morphological experiments associated with specific time-points are included
in small type in the relevant pink boxes. The gray arrows indicate the stage of
the development cycle represented by the cartoon. “PEN” represents
penicillin. “+/−” indicates that separate experiments were conducted with or
without the addition of penicillin (“+/− PEN”) or the JO146 inhibitor (“+/−
JO146”). “× PEN” indicates that penicillin was removed in the experiments
where it was added. The yellow highlighted section of the developmental
cycle indicates the expected presence and relative duration of persistence
when induced by the addition of penicillin at 4 h PI in the persistence
experiments. The cartoon representations of the expected chlamydial
developmental cycle phases and the associated time points under these
experimental conditions are based on previously published data (Byrne et al.,
2001; Miyairi et al., 2006; Skilton et al., 2009).
involve penicillin. Penicillin persistence has been described to
result in the Chlamydia cells rapidly ceasing cellular division,
whilst chromosomal and plasmid replication continue at the same
rate regardless of the presence or absence of penicillin (Byrne
et al., 2001). The removal of the penicillin then allows reversion,
which occurs via an RB budding from the aberrant body, with
this only productively occurring in some inclusions (Skilton et al.,
2009).
Recently, our team identified a serine protease inhibitor
(JO146) against C. trachomatis HtrA (CtHtrA) which was lethal
when added to cultures during the mid-replicative phase (Gloeckl
et al., 2013). The compound is a serine protease inhibitor, which
is a tri-peptide with a war-head motif. The compound was firstly
identified to be specific to CtHtrA using in vitro CtHtrA pro-
tease assays (Gloeckl et al., 2013). JO146 was demonstrated to
be lethal when added to cultures during the replicative phase of
development but not when added early or late during the devel-
opmental cycle (Gloeckl et al., 2013). HtrA in many bacteria is a
periplasmic protease involved in cell surface protein assembly and
extracytoplasmic protein maintenance (reviewed, Clausen et al.,
2011). This function is also supported by our data to date for
Chlamydia HtrA (Huston et al., 2008), and it is likely that this
extracytoplasmic protein protection role is particularly critical
during the chlamydial penicillin persistencemodel. Previously, we
and others have reported that CtHtrA is highly expressed during
penicillin persistence lab models and down regulated during IFN-
γ persistence (Belland et al., 2003; Mukhopadhyay et al., 2006;
Huston et al., 2008). Therefore, in this project we aimed to test the
hypothesis that CtHtrA is essential during penicillin persistence
using the CtHtrA inhibitor JO146.
MATERIALS AND METHODS
Chlamydia CULTURE
Chlamydia trachomatis (serovar D UW-E/Cx) was routinely cul-
tured in HEp-2 cells in DMEM (Dulbecco’s modified eagle
medium), 5% FCS (fetal calf serum), 37◦C, 5% CO2. All cultures
were conducted at a 0.3 multiplicity of infection (MOI). A sum-
mary of the experimental methods used in this study is shown in
Figure 1. Penicillin persistence was established by the addition of
100U/ml of penicillin at 4 h PI (hours post-infection) and JO146
was added at 16 h PI to determine the impact of JO146 treatment
during persistence. In order to measure the impact of JO146 on
the ultimate viability, the cultures were allowed to revert from
persistence by the removal of penicillin. Penicillin was removed
by three sequential rounds of media washes and medium was
replaced with penicillin-free media at 30 h PI. Viable infectious
yield was measured at 68, 78, and 90 h PI. Cultures were also
monitored for viability at 44 h PI without the removal of the peni-
cillin to demonstrate lack of viability consistent with persistence
(in conjunction with the ability to subsequently rescue these same
culture conditions to detectable viability by penicillin removal).
Control cultures with no JO146 were included for each experi-
ment and with the solvent DMSO (dimethyl sulfoxide). In order
to assess the impact of JO146 on Chlamydia during reversion
from penicillin persistence, a separate experiment was conducted
where persistence was induced in the cultures using penicillin (4 h
PI, 100Uml-1); at 40 h PI the penicillin was removed (washes and
media change). At 52 h PI when reversion is likely to be underway
in most inclusions, JO146 was added to the cultures (concentra-
tions as indicated on the figures). Reversion is very asynchronous
from this form of persistence. Reversion has been reported to take
10–20 h for C. trachomatis L2 which has similar (slightly faster)
growth kinetics to the strain used in this study. Therefore, 52 h PI
is the most logical choice to target reversion based on available
data (Skilton et al., 2009). The cultures were harvested and viabil-
ity was determined at 84, 90, and 100 h PI. Control cultures with
no JO146 treatment were included for each experiment. Cultures
for immunocytochemistry were conducted on glass coverslips,
using the method previously described (Huston et al., 2008).
A heat shock model was used in conjunction with JO146
treatment to evaluate the role of CtHtrA for chlamydial viabil-
ity during heat stress. Heat shock was conducted at 20 h PI for 4 h
(20–24 h PI), as we have previously shown an increase in CtHtrA
protein at this time point during heat shock (Huston et al., 2008).
JO146 was added at 20 h PI, immediately prior to heat shock at
42◦C, 5% CO2 for 4 h. At the conclusion of the 4 h heat shock,
JO146 was removed from the cultures by three washes in 37◦C
pre-warmed media, prior to returning the culture to 37◦C for
the remainder of the developmental cycle. In a separate experi-
ment, the role of CtHtrA during recovery from heat shock was
also analyzed by the addition of JO146 immediately (at 24 h PI)
after the 4 h heat shock treatment and removal of the compound
by media washes (three) at 28 h PI. The cultures were harvested at
44 h PI and viable infectious yield was determined (see Figure 1
summary).
DETERMINATION OF CHLAMYDIAL VIABILITY
Chlamydia viable infectious yield was determined by serial dilu-
tion of cultures and infection on HEp-2. At 30 h PI the mono-
layers were fixed and immunocytochemistry was conducted to
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FIGURE 2 | Confocal microscopy images of JO146 treated cultures
during penicillin persistence at 44h PI (+PEN: penicillin added, −PEN:
no penicillin). The figure shows representative images from confocal laser
(Continued)
FIGURE 2 | Continued
scanning microscopy of cultures fixed at 44 h PI, 100U ml−1penicillin was
added at 4 h PI. Representative images from the control culture shown in
the left column (−PEN). Penicillin treated conditions are shown in the right
column. JO146 treatment conditions are indicated to the right (0, 10, 50,
100μM, DMSO). The final images at the bottom are enlarged images of the
controls which have both had equal contrast adjustments to make the
differences more apparent (0μM JO146 enlarged). The image colors are as
follows, green: MOMP (major outer membrane protein) is green, blue: cell
nucleus (DAPI), and red: β-actin. Scale bar (bottom right) indicates 10mm.
∗Indicates zoomed in images from the 0μM conditions are shown to allow
closer examination of morphology.
FIGURE 3 | Inclusion sizes and viable infectious yield during penicillin
persistence at 44h PI with and without JO146 treatment. The figure
shows morphological analysis of cultures during penicillin persistence and
controls by measuring inclusion sizes. The viable infectious yield (44 h PI) in
the presence or absence of 100 U ml−1 penicillin (4 h PI) is shown on the
graph. (A) Inclusion sizes are shown from each condition inclusion sizes
were measured from independent coverslips, n = 20. (B) Viable infectious
yield with and without penicillin are shown graphically (n = 27). Statistics
were conducted using Two-Way ANOVA relative to DMSO controls,
p > 0.5∗, p > 0.01∗∗, p > 0.001∗∗, P > 0.0001∗∗∗.
enable counting of inclusions. The final results are presented
as inclusion forming units per ml (IFU ml−1). Statistical anal-
ysis was performed using PRISM (GraphPad Software Inc).
Results are expressed as mean, with error bars representing
standard error of the mean. Two-Way analysis of variance
(ANOVA) with a post-hoc Bonferroni multiple comparison tests
was used to assay the statistical differences relative to the DMSO
control.
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FIGURE 4 | Viable infectious yield of C. trachomatis after treatment
with JO146 during penicillin persistence. The figure shows viable
IFU ml−1from each culture condition at several time points after
reversion was commenced (penicillin removal at 30 h PI). Cultures
were treated with penicillin 100U ml−1 at 4 h PI, and with JO146 at
16 h PI (concentrations indicated by the gray shading, see key to the
right of each graph). Penicillin was removed from the cultures at 30 h
PI. (A) Viable infectious yield from penicillin treated and restored
cultures. (B) Viable infectious yield from control cultures which did not
have penicillin added. Statistics were conducted using Two-Way
ANOVA relative to DMSO controls.
IMMMUNCYTOCHEMISTRY AND MICROSCOPY
Cultures were fixed using 4% paraformaldehyde-PBS (phosphate
buffered saline) for 15min, and then blocked in 1% BSA-PBS
overnight at 4◦C. The primary antibody (C. trachomatis MOMP
(major outer membrane proteim), Biodesign International) was
added at 1:500 dilutions in 1% BSA (bovine serum albu-
min) in PBS with 2μL/coverslip phalloidin 594 (Invitrogen)
and 1:40,000 dilution of DAPI (diaminidino phenylindole).
Coverslips were incubated for 2 h at room temperature. Three
washes with 0.2% Tween 20 in PBS were conducted prior
to addition of the secondary antibody (goat anti-mouse IgG
H+L-Alexa Flour 488, Invitrogen) at 1:2000 dilutions in 1%
BSA in PBS. Coverslips were then washed 4 times with
0.2% Tween 20-PBS and were suspended in PBS prior to
mounting with ProLong Gold (Invitrogen). Cultures fixed for
immunocytochemistry were examined using the Leica SP5 con-
focal microscope. Images were prepared using the supplied
Leica software suite. Sizes of inclusions at 44 h PI were mea-
sured to determine the effect of the inhibitor compound dur-
ing penicillin-induced persistence using the Leica application
suite.
FIGURE 5 | Confocal microscopy images of C. trachomatis cultures at
68h PI, or 38h after penicillin reversion commenced. Cultures were
treated with penicillin 100U ml−1 (right column) at 4 h PI, and with JO146
at 16 h PI (concentrations indicated by the gray shading, legend to right of
each graph). Penicillin was removed from the cultures at 30 h PI. The image
colors are as follows, green: MOMP (major outer membrane protein) is
green, blue: cell nucleus (DAPI), and red indicates β-actin. Scale bar (bottom
right) indicates 10μm.
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RESULTS
JO146 ADDITION TO C. trachomatis HEp-2 CULTURES DURING
PENICILLIN PERSISTENCE RESULTS IN A REDUCED VIABLE YIELD
Due to the bi-phasic nature of the chlamydial developmental cycle
it is not possible to measure the immediate impact on viabil-
ity during the replicative phase of growth. Therefore, for each of
these experiments we have assessed the viability once elementary
bodies are formed, either at the conclusion of the developmen-
tal cycle or once reversion from persistence and development
of elementary bodies has occurred. This also means that we
can confirm that the cultures are persistent by detection of loss
of viability in the persistent cultures when control cultures are
demonstrated to have viable elementary bodies (as long as via-
bility was subsequently restored by removal of the persistence
inducing agent). We first wanted to monitor the impact of JO146
addition during persistence when aberrant bodies are present,
hence for this experiment we added JO146 during persistence at
16 h PI (penicillin was added at 4 h PI to induce persistence) and
one set of cultures were harvested to measure viability and also
fixed and examined by confocal microscopy at 44 h PI. A sec-
ond set of cultures were media changed at 30 h PI to remove
both the JO146 and penicillin and harvested at 68, 78, and 90 h
PI (or 38, 48, 60 h after penicillin removal) to allow time for
reversion from persistence and elementary body formation (as
outlined in Figure 1). These cultures were tested for viability
and morphology was examined using confocal laser scanning
microscopy.
The cultures were firstly confirmed to be persistent at 44 h
PI by monitoring viability and impact of JO146 treatment in
the presence and absence of penicillin. As shown in Figure 2,
the cultures treated with penicillin had much smaller inclusions
compared to the controls at 44 h PI. The inclusions were also
much less populated with cell shaped bodies consistent with a
persistent phenotype (Figure 2 right column penicillin compared
to control left column). The increasing concentrations of JO146
resulted in a decreased inclusion vacuole size for both the peni-
cillin treated and control cultures (Figure 3A). The penicillin
treated cultures were confirmed to be persistent by a lack of
viable EBs at 44 h PI (Figure 3B) and supported by restoration
of viability in subsequent experiments.
The viable infectious yield during the reversion from persis-
tence from the cultures with and without JO146 treatment was
determined [during reversion at 68, 78, and 90 h PI, when we
expect to see recovery to viable elementary bodies (Skilton et al.,
2009)]. As expected, and consistent with our previously published
data, JO146 was completely lethal on the control (non-persistent)
culture at 50 and 100μM, when viability was measured at 44 h
PI (Figure 3B) with some recovery of viability observed at the
later time points (extended culture conditions, Figure 4B), as
consistent with our previous work (Gloeckl et al., 2013). In con-
trast, JO146 was not lethal when it was added at the same time
point during penicillin induced persistence (Figure 4A). Cultures
were treated with JO146 during persistence then subsequently res-
cued by media change (30 h PI) to allow the formation of EBs
(measured as viable infectious yield). JO146 treatment during the
persistence phase resulted in a relatively minor loss of detectable
viability, with approximately a 1 log reduction of viable yield
observed at 100μM JO146 when EBs were able to be detected
FIGURE 6 | Penicillin persistence cultures prior to commencement of
reversion are not viable and are morphologically consistent with
persistence. Cultures were treated with penicillin 100U ml−1 at 4 h PI.
(A) Confocal microscopy image of cultures at 40 h PI in the presence
of penicillin (+PEN) (B) Confocal microscopy image of cultures at 40 h
PI in the absence of penicillin (−PEN). The scale bar indicates 25μm.
(C) Viable infectious yield of the corresponding cultures (n = 27). (D)
Enlarged area of A: confocal microscopy image of cultures at 40 h PI in
the presence of penicillin (+PEN). (E) Enlarged area of B: confocal
microscopy image of cultures at 40 h PI in the absence of penicillin
(−PEN). The contrast has been equally adjusted on D,E to improve the
visibility of the morphologies present.
Frontiers in Cellular and Infection Microbiology www.frontiersin.org December 2013 | Volume 3 | Article 100 | 6
Ong et al. CtHtrA essential for penicillin reversion
at 68, 78, and 90 h PI (Figure 4A). The control cultures which
were not persistent showed ∼2–3 log reductions in viability
with 100μM JO146 treatment at the extended culture times of
68–90 h PI (Figure 4B). This observation of reduced effectiveness
of JO146 over extended culture conditions is consistent with our
previous data (Gloeckl et al., 2013).
The cultures were monitored by immunofluorescence dur-
ing the reversion period and representative images from 68 h
PI are shown in Figure 5 (left column control, right column
penicillin). The penicillin treated cultures had smaller inclu-
sions with different appearance (likely indicating there are still
aberrant bodies present) at 68 h PI, with the inclusions gen-
erally appearing smaller in the presence of 100μM JO146
(Figure 5, right column). The control cultures (no penicillin
treatment) also showed a JO146 concentration dependent reduc-
tion of the inclusion sizes (Figure 5, left column). However,
even though the inclusions appeared markedly smaller when
recovering from penicillin persistence at 68 h PI, there was only
∼one log reduction in viable EB yield compared to the controls
(Figure 4A).
JO146 ADDITION TO C. trachomatis HEp-2 CULTURES DURING
REVERSION FROM PENICILLIN PERSISTENCE IS LETHAL
The mechanism of reversion from penicillin persistence has been
described to be very asynchronous; with gradual budding of “nor-
mal” RBs from the aberrant persistent forms in the inclusion
over 10–20 h after penicillin was removed (Skilton et al., 2009).
These budded RBs are then thought to undergo replication by
binary fission prior to conversion to the infectious elementary
body form. Given the highly asynchronous nature of this rever-
sion, at any one time there will be cells undergoing reversion
and other cells undergoing replication at the same time, mean-
ing that it is not possible to uncouple reversion from replication.
We established penicillin persistent cultures and then commenced
reversion by washing and media change at 40 h PI. 12 h (52 h PI)
after reversion was commenced we added JO146 and monitored
the formation of viable infectious elementary bodies at 84, 90, and
100 h PI.
Firstly, we confirmed that the cultures were persistent at 40 h
PI by measuring viability and examining the morphology of the
cultures using confocal laser scanning microscopy. As shown in
Figure 6, the penicillin treated cultures were not viable at 40 h
PI (Figure 6C) and morphologically the inclusions were smaller
and appeared to have large cellular forms present inside each
inclusion (Figures 6A,B). The penicillin persistent cultures were
washed to remove penicillin to commence reversion at 40 h PI.
JO146 was added to these cultures 12 h after commencement of
reversion (i.e., 52 h PI). Viable infectious yield was then measured
over time from the cultures. As shown in Figure 7A no viable
Chlamydia were detected at 84 h PI from the persistence rever-
sion cultures (44 h after penicillin was removed), however, at 90
and 100 h PI viable EBs were detected. The JO146 treatment of
100μM JO146 was lethal to the cultures undergoing reversion
(Figure 7A). In contrast, the cultures which were not penicillin
persistent showed only minor reductions in viability due to the
addition of JO146 (Figure 7B). These control cultures were likely
either mainly in elementary body form or in the early stages of
FIGURE 7 | Viable infectious yield when JO146 was added during the
reversion from penicillin persistence. Cultures were treated with
penicillin 100U ml−1 at 4 h PI. Penicillin was removed at 40 h PI and JO146
treatment was commenced at 52 h PI. (A) JO146 was added 12 h after
penicillin persistence reversion was commenced (i.e., at 52 h PI).
(B) Control cultures that were not persistent with JO146 treatment also
conducted at 52 h PI. The graphs show the viable infectious yield at several
time points after reversion from persistence was commenced (n = 27).
JO146 concentration is indicated by the gray shading (legend to the right of
each graph).
infection when JO146 was added (early or very late developmental
cycle, or a mix of both), based on the morphological appear-
ance of the inclusions and what we know about the timing of
the chlamydial developmental cycle. We previously demonstrated
that JO146 was less effective for both of these developmental
phases (Gloeckl et al., 2013), so these results are consistent with
what might be expected. Therefore, these data indicate that dur-
ing reversion from penicillin persistence and recovery of viability,
JO146 treatment is completely lethal for Chlamydia.
We monitored the appearance of the cultures using immuno-
cytochemistry and confocal laser scanning microscopy during
the reversion from persistence to monitor the impact of JO146
on inclusion morphology at 64 and 70 h PI (12 and 18 h after
JO146 addition). In this case we observed no obvious decrease
in the inclusion size relating to JO146 treatment (Figure 8, sec-
ond and fourth column), and as expected the inclusions from the
persistent cultures were much smaller than those in the controls
(Figure 8 controls first and third column).
JO146 TREATMENT IS LETHAL DURING HEAT STRESS AND RECOVERY
FROM HEAT STRESS FOR Chlamydia
In many bacteria, HtrA is widely acknowledged to be a stress
response protease as well as being involved in crucial functions
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FIGURE 8 | Confocal microscopy images of penicillin persistent cultures
and controls during reversion from persistence at 64 and 70hPI. Cultures
were treated with penicillin 100U ml−1 at 4 h PI. Penicillin was removed at
40 h PI and JO146 treatment was commenced at 52 h PI. Controls with no
penicillin first and third column, penicillin conditions second and fourth
columns. JO146 concentrations are indicated to the right. The image colors
are as follows, green: MOMP (major outer membrane protein) is green, blue:
cell nucleus (DAPI), and red: β-actin. Scale bar (bottom right) indicates 10μm.
in outer membrane protein assembly and general protein main-
tenance (reviewed, Clausen et al., 2011). Accordingly, we used
JO146 to evaluate the role of CtHtrA during heat stress and
also during recovery from heat stress. We had previously shown
increased protein levels of CtHtrA during a heat stress model, at
20 h PI, and this is also the phase of the developmental cycle at
which we already know JO146 is effective (Huston et al., 2008;
Gloeckl et al., 2012). C. trachomatis cultures (20 h PI) were heat
stressed for 4 h in a 42◦C 5% CO2 incubator prior to subse-
quent restoration to 37◦C and completion of the developmental
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FIGURE 9 | C. trachomatis viable infectious yield at 44h PI after 4 h
heat shock with JO146 treatment (20–24h PI) or JO146 treatment
during recovery from heat shock (24–28h PI). (A) The viable infectious
yield after JO146 treatment for 4 h at 20 h PI with and without heat shock at
42◦C. (B) Viable infectious yield after JO146 treatment for 4 h during
recovery from heat shock (24–28 h PI) (n = 27). The concentration of JO146
is indicated by the gray scale bars, legend to the right of each graph.
cycle. JO146 was added either during the heat shock and subse-
quently removed, or during the 4 h of post heat shock recovery
and subsequently removed. The impact of JO146 treatment and
the heat shock conditions were evaluated by determining the
viable infectious yield at 44 h PI. In our previous work using
JO146 we demonstrated that the compound needed to be present
for longer than 4 h for lethality, therefore, during this experi-
ment we used a higher concentration of 150μM. As shown in
Figure 9A, the presence of JO146 during heat shock was com-
pletely lethal at 100 and 150μM. 50μM JO146 treatment during
the 4 h heat shock also resulted in a marked loss of chlamydial
viability (>2 log) (Figure 9A). Some JO146-induced reduction
in viability was also observed in the controls which were not
heat shocked (Figure 9A, indicated on x axis), and this is con-
sistent with our previous observations that JO146 needs to be
present throughout the replicative phase (not for 4 h only) to be
completely lethal (Gloeckl et al., 2013).
JO146 treatment during the first 4 h of recovery from
heat shock was also completely lethal at higher concentrations
(100μM and 150μM), with a minor impact on viable yield
observed with 50μM JO146 (Figure 9B). There was a more
noticeable reduction in viability for the heat shocked cultures
compared to the controls during this experiment (Figure 9B, con-
ditions indicated on x axis). However, in spite of these differences
it is clear that JO146 treatment both during heat stress and recov-
ery from was lethal for Chlamydia, with a more marked impact at
lower concentrations during the heat stress.
DISCUSSION
HtrA is an essential maintenance protease and chaperone for
many bacteria. The protein conducts diverse roles in bacterial
pathogenesis from being essential for outer membrane protein
assembly (Purdy et al., 2007), to stress response and survival
(Lipinska et al., 1989), cleavage of host proteins (Hoy et al., 2010)
and intracellular infection survival (Pedersen et al., 2001). We
previously used a chemical inhibition strategy to establish that
ChlamydiaHtrA (CtHtrA) is essential during the replicative phase
of intracellular development. Using JO146 we found that CtHtrA
inhibition at 16 h PI resulted in the reduction of inclusion sizes
and eventually the inclusions were lost from the host cells with no
detectable production of viable elementary bodies (Gloeckl et al.,
2013). This data supports an essential role for CtHtrA during the
replicative phase of chlamydial development. However, given the
multi-tasking nature of HtrA already described for many other
bacteria (reviewed, Clausen et al., 2011), we set out to test the
hypothesis that CtHtrA is essential for heat stress conditions and
during persistence models.
The data we present demonstrates that CtHtrA is essential for
the reversion and recovery to viability for penicillin persistence
and is also essential during heat stress and recovery from heat
stress. The heat stress model is clearly likely to involve extra-
cytoplasmic protein stress which will require both the protease
activity and chaperone activity of CtHtrA. Clearly CtHtrA is
essential, either for stress response or restoration of protein bio-
genesis, during the reversion and recovery to EBs from penicillin
persistence. The recovery from penicillin persistence is very asyn-
chronous and so it was not possible to uncouple restoration from
persistence and the subsequent replication of the restored RBs.
Therefore, it is possible that the impact of JO146 in this experi-
ment was on the replication of recovered RBs or the recovery from
penicillin persistence to reticulate bodies, or both. However, 44 h
after reversion was commenced no viable EBs were detectable but
they were at 50 h, which does suggest that the JO146 treatment
was during the time frame likely to correspond with the majority
of the population still undergoing reversion from persistence.
Based on the lack of lethality in the first model when JO146
was added during persistence, it is tempting to suggest that
penicillin persistence does not involve a detrimental level of extra-
cytoplasmic protein stress. It is important to note that there
is a possibility of some off-target impacts of JO146, however,
given themarked phenotypes which correspond with very specific
phases and conditions of chlamydial culture observed here, these
impacts are likely minor. The absolute requirement for CtHtrA
during recovery from penicillin persistence is an exciting find-
ing, and to our knowledge is the first identification of an essential
protein for this transition. In addition, JO146 treatment in the
presence of heat stress in a time frame (4 h) was completely
lethal. This is amazingly quick given 4 h is consistent with less
than 2 rounds of binary fission for C. trachomatis serovar D [has
been identified to take 2.4 h per round of binary fission (Miyairi
et al., 2006)]. This suggests that CtHtrA is essential during certain
stress conditions and does not necessarily relate to replication or
binary fission. This data suggests that perhaps penicillin persis-
tence is a strategy to reduce cellular and protein stress which may
be an explanation for why CtHtrA was found not to be essential
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during penicillin persistence. Heat stress is highly likely to be a
strong inducer of protein stress and for many bacteria is the main
in vitro condition during which htrA- or degP- mutants are lethal
(Lipinska et al., 1989). Therefore, it is not surprising that CtHtrA
was essential even in this relatively short time of heat treatment. In
summary, the data presented here demonstrates that the CtHtrA
inhibitor JO146 is lethal for chlamydial recovery from penicillin
persistence and for heat stress conditions.
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